FDA Investigator Muoi N Hoang
Muoi N Hoang has conducted inspections on 9 sites in 1 countries as of 29 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
9
Last Inspection Date:
29 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Muoi N Hoang:
Angel K Sandhu,
Angelica Ornelas,
Ashley S Ertzman,
Breena L D'ambrogi,
Brian P Putz,
Bruce D Broidy,
Christine M Parmentier,
Daniel J Roberts,
David Y Hernandez,
Davis,
Deborah K Richardson,
Dejon N Harris,
Dena L Jacobs,
Edna J Hidalgo,
Eric W Anderson,
Gillenwater,
Greg K Keshishyan,
Hunter M Vice,
Jacqueline O Snell,
Jane G Choi,
Janice Wai,
Jeanne A Young,
John Cheung,
Juan A Morales,
Julia Ventura,
Juliane Kjung Lau,
Karen D Phung,
Karla J Gibler,
Kevin P Foley,
Kevin T Gerrity,
Kin T Moy,
Larkin R Buckalew,
Mabel M Lee,
Margo C Jones,
Mark I Nakano,
Mary C Wall,
Mcgrewp,
Nicole Yuen,
Phillip L Toy,
Phung,
Quynh H Strandberg,
Richard W Tubb,
Riley C Graham,
Sandra S Saniga,
Tuan D Tran,
Wayne L Jefferson,
William V Millar,
Yen Tso Kuo
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more